Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |